CoreWeave (CRWV) officer files Form 4 on Rule 10b5-1 stock sales
Rhea-AI Filing Summary
CoreWeave, Inc. disclosed that its Chief Development Officer, reporting through a Form 4, oversaw multiple small sales of Class A common stock on December 15, 2025. The shares were sold indirectly through the Canis Major SM Trust, an irrevocable trust for the reporting person’s minor child, under a Rule 10b5-1 trading plan adopted on September 2, 2025.
The reported sale prices were weighted averages for transactions executed in ranges from $72.19 to $79.06. After these transactions, the trust held 58,500 shares of Class A common stock, and the reporting person’s child held an additional 1,800 shares of Class A common stock of record.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 202 | $72.524 | $15K |
| Sale | Class A Common Stock | 222 | $73.7295 | $16K |
| Sale | Class A Common Stock | 31 | $74.5374 | $2K |
| Sale | Class A Common Stock | 18 | $76.355 | $1K |
| Sale | Class A Common Stock | 18 | $78.855 | $1K |
| Sale | Class A Common Stock | 9 | $79.69 | $717.21 |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.19 to $73.01, inclusive. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.16, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.30 to $74.94, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.97 to $76.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.06, inclusive. The reported securities are directly held of record by the reporting person's child.
FAQ
What did CoreWeave (CRWV) report in this Form 4 filing?
The filing reports that CoreWeave’s Chief Development Officer had multiple small sales of Class A common stock on December 15, 2025, indirectly through a family trust and a minor child’s account.
Were the CoreWeave (CRWV) stock sales made under a Rule 10b5-1 plan?
Yes. The filing states that the reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
What price ranges were involved in the CoreWeave (CRWV) stock sales?
The filing reports weighted average sale prices, with individual transactions executed in ranges from $72.19 to $73.01, $73.20 to $74.16, $74.30 to $74.94, $75.97 to $76.74, and $78.65 to $79.06.
What is the relationship of the reporting person to CoreWeave (CRWV)?
The reporting person is an officer of CoreWeave, serving as Chief Development Officer, and is not identified as a director or 10% owner in the check-box section.